Evidence map›Paper›PMID 35288722›Full record

ArticleNature metabolism2022

Angiocrine polyamine production regulates adiposity.

Erika Monelli, Pilar Villacampa, Amaia Zabala-Letona, Anabel Martinez-Romero, Judith Llena, Daniel Beiroa, Leonor Gouveia, Iñigo Chivite, Sebastián Zagmutt, Pau Gama-Perez and 20 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. mInternational journal of molecular medicine · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Tumor-Derived Polyamines Initiate Fat Wasting in Cancer Cachexia.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Microenvironmental determinants of endothelial cell heterogeneity.Nature reviews. Molecular cell biology · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 13 institutions in 3 countries.

Erika MonelliEndothelial Pathobiology and Microenviroment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-0541-0602
Pilar VillacampaEndothelial Pathobiology and Microenviroment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2860-7475
Amaia Zabala-LetonaCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.
Anabel Martinez-RomeroEndothelial Pathobiology and Microenviroment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.
Judith LlenaEndothelial Pathobiology and Microenviroment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5648-2606
Daniel BeiroaCIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0003-1862-1668
Leonor GouveiaEndothelial Pathobiology and Microenviroment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-3825-8571
Iñigo ChiviteNeuronal Control of Metabolism Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Sebastián ZagmuttDepartment of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain.
Pau Gama-PerezDepartment of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona and Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Oscar Osorio-ConlesDepartment of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-0285-5526
Laia MuixiEndothelial Pathobiology and Microenviroment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.
Ainara Martinez-GonzalezCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.
Sandra D CastilloEndothelial Pathobiology and Microenviroment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-7007-3155
Natalia Martín-MartínCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.
Pau CastelDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-4972-4347
Lorea Valcarcel-JimenezCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.ORCID http://orcid.org/0000-0002-7309-9924
Irene Garcia-GonzalezMolecular Genetics of Angiogenesis Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.ORCID http://orcid.org/0000-0001-8508-8344
Josep A VillenaCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Sonia Fernandez-RuizCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.
Dolors SerraCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-4936-4206
Laura HerreroCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0003-4244-4673
Rui BeneditoMolecular Genetics of Angiogenesis Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.ORCID http://orcid.org/0000-0003-2458-3055
Pablo Garcia-RovesCentro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-8371-2067
Josep VidalDepartment of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.
Paul CohenLaboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA.
Rubén NogueirasCIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-9976-9930
Marc ClaretNeuronal Control of Metabolism Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID http://orcid.org/0000-0001-7766-9296
Arkaitz Carracedo *Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.ORCID http://orcid.org/0000-0001-5957-1260
Mariona Graupera *Endothelial Pathobiology and Microenviroment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain. mgraupera@carrerasresearch.org.ORCID http://orcid.org/0000-0003-4608-4185
Instituto de Salud Carlos III · ESJosep Carreras Leukaemia Research Institute · ESCIC bioGUNE · ESSpanish National Centre for Cardiovascular Research · ESUniversidade de Santiago de Compostela · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESIkerbasque · ESInstitut de Biomedicina de la Universitat de BarcelonaInstitut d'Investigació Biomédica de Bellvitge · ESNew York University · USRockefeller University · USUniversitat Autònoma de Barcelona · ESUppsala University · SE

Funding

The role of Sin1 in Kras-driven cancerK99CA245122 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CASTEL, PAU · 2020 to 2021
$214k
NCI NIH HHS K99 CA245122
6 · The paper itself

Abstract

Reciprocal interactions between endothelial cells (ECs) and adipocytes are fundamental to maintain white adipose tissue (WAT) homeostasis, as illustrated by the activation of angiogenesis upon WAT expansion, a process that is impaired in obesity. However, the molecular mechanisms underlying the crosstalk between ECs and adipocytes remain poorly understood. Here, we show that local production of polyamines in ECs stimulates adipocyte lipolysis and regulates WAT homeostasis in mice. We promote enhanced cell-autonomous angiogenesis by deleting Pten in the murine endothelium. Endothelial Pten loss leads to a WAT-selective phenotype, characterized by reduced body weight and adiposity in pathophysiological conditions. This phenotype stems from enhanced fatty acid β-oxidation in ECs concomitant with a paracrine lipolytic action on adipocytes, accounting for reduced adiposity. Combined analysis of murine models, isolated ECs and human specimens reveals that WAT lipolysis is mediated by mTORC1-dependent production of polyamines by ECs. Our results indicate that angiocrine metabolic signals are important for WAT homeostasis and organismal metabolism.

Indexed as

AdiposityEndothelial CellsAnimalsMiceMice, Inbred C57BLObesityPolyaminesPolyamines

Identifiers

PMID35288722
OpenAlexW4220762080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.